Grant directory

Open

Supports translating decades of ageing biology into biotech or pharma proofs-of-concept that prevent, delay or revert age-related disease.

Open

Funds French and Taiwanese companies developing joint R&D projects through coordinated national innovation aid.

Open

Funds research consortia developing biotechnology-based interventions, biomarkers or non-animal test methods that target the root causes of age-related disease.

Open

Funds institutions hosting Canada Impact Chairs through major infrastructure support.

Open

Test an academic-industry functional-genomics idea and generate early data.

Open

Funds a clinical trial of a new autism treatment, product or device, from a small proof-of-concept study up to a full efficacy trial.

Open

Funds a conceptually new, unproven idea in tick-borne disease research — not an incremental step on work that is already published or underway.

Open

Funds either a drug-discovery study or a clinical diagnostic approach for Lyme disease and other tick-borne diseases, aimed at something a clinic could use.

Open

Funds European consortia developing breakthrough solutions across AI, climate, energy, materials, medical, and quantum fields.

Open

Funds early-stage clinical trials in arthritis, musculoskeletal and skin disease. A trial is compulsory.

Open

Funds short visits by diaspora scientists to strengthen Moroccan research links.

Open

Funds the one centre that coordinates a rare-disease genomics programme and gets its protocols, data and tools out to everybody else.

Open

Funds a genuinely new experimental or computational approach to finding the cause of a rare genetic disorder, where the current state of the art falls short.

Open

Funds the centre that turns new molecular methods for rare-disease diagnosis into standards, best practices and a benchmarking dataset.

Open

Funds major dementia research programs in the United Kingdom through multi-year grants.

Open

Supports early life science teams at Michigan institutions by guiding proof of concept work toward development.

Open

Supports MTRAC life sciences teams with mid-stage funding that advances prototypes toward clinical and industry use.

Open

Funds early dementia science concepts in the United Kingdom with exploratory research support.

Open

Funds nothing — it hands over urine, plasma, serum and DNA from the national tobacco and health study. The research costs stay yours.

Open

Funds Princeton investigators moving university inventions toward licensing through proof-of-concept and prototype grants.

Open

Supports recently tenured faculty with fellowships that enable bold cross-domain research pivots and sustained interdisciplinary leadership.

Pays high school students in South Dakota, North Dakota and Minnesota cash prizes and scholarships for their best business idea.

Open

Co-funds Polish SMEs and larger firms building market-ready tech with a partner in another EUREKA country.

Open

Funds Canadian firms in EUREKA low-carbon energy R&D consortia.